Inhaled iloprost for COPD with pulmonary hypertension
Part of Heart & circulation, Lungs & breathing clinical trials.
This trial tests a new way to help people who have both severe COPD and a type of high blood pressure in the lungs. The study uses an inhaled medication called iloprost to see if it can improve blood flow and reduce symptoms.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 40 years old or older.
- You need to have severe or very severe COPD (GOLD stage 3 or 4).
- You must have pulmonary hypertension that causes symptoms, confirmed by a right heart catheterization test.
- The heart test must show certain high pressures and a low wedge pressure (meaning the problem is from your lungs, not your heart).
- You cannot be allergic to the study drug (iloprost), and cannot be pregnant or breastfeeding.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 2 trial is for adults with pulmonary hypertension who are on the lung transplant waiting list at Duke. It aims to test whether the study treatment can improve lung pressure and related health outcomes, while using things like MRI to monitor changes.
This trial tests an inhaled medicine that may help people with lung scarring or connective tissue disease who have high blood pressure in the lungs only during exercise. It aims to improve their ability to be active and reduce symptoms.
This study tests a medicine called prostacyclin (given through a vein) to see if it helps people on a breathing machine with a lung infection. The goal is to reduce inflammation and improve recovery.
This study tests an inhaled powder medication called TPIP (treprostinil palmitil inhalation powder) to see if it can improve symptoms and exercise ability in people who have both interstitial lung disease and pulmonary hypertension. The study will compare TPIP against a placebo (a dummy treatment without the active drug) to understand how well it works and if it is safe.
This trial tests whether an inhaled medication called treprostinil (which helps open blood vessels in the lungs) can improve exercise ability in people who get high blood pressure in the lungs only during exercise. Participation involves taking the medication and doing exercise tests to see how well you do.
This program provides access to an inhaled medication called treprostinil for people who have pulmonary hypertension (high blood pressure in the lungs) related to interstitial lung disease (a type of lung scarring). The treatment aims to improve symptoms and quality of life.
Hear when a new COPD trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.